Skip to content

Events & Presentations

Investor Events

Optimum Healthcare Investor Conference

8 October 2026

London

Peel Hunt Growth Conference

13-14 October 2026

London

Jefferies London Healthcare Conference

16-19 November 2026

London

ICR Healthcare Annual Conference

16 November 2026

London

Financial Calendar

FY 2026 Trading Update

Q1 2027

FY 2026 Results

Q1 2027

AGM

Q2 2027

HY 2027 Trading Update

Q3 2027

HY 2027 Interim Results

Q3 2027

Past Presentations

View all
23 Jul 2026 8 mins

hVIVO order book tops £65m as CEO backs strong H2 recovery

CEO Yamin 'Mo' Khan joined Proactive's Stephen Gunnion to discuss the company's latest trading update, highlighting a record order book of more than £65 million that supports expectations for a much stronger second half of 2026.

11 Jun 2026

Capital Markets Day 2026

View the presentations given at our Capital Markets Day 2026.

15 Apr 2026 9 mins

hVIVO FY25 Results: Growth, Acquisitions and What Comes Next in 2026

CEO Yamin 'Mo' Khan joined Proactive's Stephen Gunnion to discuss the company's latest trading update, highlighting a record order book of more than £65 million that supports expectations for a much stronger second half of 2026.

29 Jan 2026 36 mins

Trading Update FY25

HVIVO plc (HVO:AIM) reported an unaudited FY25 trading update highlighting resilient company performance amid a challenging macro backdrop, with revenue of £46.7 million in line with revised guidance and a positive low single-digit adjusted EBITDA margin, outperforming market expectations.

23 Sep 2025 42 mins

HVIVO PLC - Interim Results

Welcome to the HVO PLC interim results investor presentation.

22 Jul 2025 37 mins

H1 25 Trading Update

hVIVO's first half 2025 trading update, presented by Yamin Khan

10 Apr 2025 55 mins

Full Year Results 2024

Financial performance was a record year for hVIVO and also a transformational one for operations.

Investor Quick Links

Results Centre

Access all the latest results and presentations

Regulatory News

Learn more

Environmental, Social & Governance

Learn more 

Share Price Information

Learn more 

AIM Rule 26

Learn more 

Media Library

Learn more 

Company Documents

Learn more

Contact our Investor Relations team.

Email IR team